UNC13A splice correction rescues synaptic dysfunction induced by TDP-43 loss

Researchers have identified that correcting a specific splicing defect in the UNC13A gene can rescue synaptic dysfunction caused by TDP-43 loss. This discovery offers a potential therapeutic pathway for the vast majority of ALS and frontotemporal dementia patients who exhibit TDP-43 pathology.
Why it matters
This provides a genetically validated therapeutic target for neurodegenerative diseases that currently lack effective treatments for most patients.
TDP-43 nuclear depletion is a defining pathological feature of amyotrophic lateral sclerosis and frontotemporal dementia that induces widespread cryptic splicing defects in hundreds of transcripts 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 . Despite this, whether TDP-43 loss affects synaptic function has remained unclear. Here we show that TDP-43 loss induces a predegenerative state in which neurons remain structurally intact but suffer a substantial breakdown in synaptic communication. Genetic correction of a single cryptic splicing event in UNC13A was sufficient to rescue these deficits. We developed splice-switching antisense oligonucleotides that correct UNC13A cryptic splicing in human cortical and spinal motor neurons and in a humanized mouse model. In human neurons this intervention restored spontaneous and evoked synaptic vesicle release, release probability at individual synapses and wider network synchrony.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in